E.E. Geduld’s Precigen PGEN Stock Holding History

E.E. Geduld’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-15,179	Closed	-$734K	–	257
2015 Q2	$734K	Buy	15,179 +4,670	+44%	+$197K	0.46%	39
2015 Q1	$456K	Buy	10,509 +46	+0.4%	+$1.65K	0.3%	78
2014 Q4	$275K	Buy	+10,463	New	+$229K	0.15%	117
2014 Q3	–	Sell	-20,927	Closed	-$503K	–	270
2014 Q2	$503K	Buy	+20,927	New	+$424K	0.31%	74

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UOTTAIMCU

University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Third Point New York $2.08B AUM 27.04% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

E.E. Geduld's PGEN Position: Q3 2015 in Review

E.E. Geduld sold out of Precigen (PGEN) in Q3 2015, closing a stake of 15,179 shares — an estimated $734K sold.

E.E. Geduld first reported a position in PGEN in Q2 2014 and held it in 4 quarters. The position peaked at $734K in Q2 2015. 173 funds tracked by Wall St. Rank hold PGEN as of Q3 2015.

E.E. Geduld reported no remaining Precigen position as of Q3 2015 after selling out during the quarter.
E.E. Geduld sold 15,179 Precigen shares in Q3 2015, an estimated $734K.
E.E. Geduld first reported a position in Precigen in Q2 2014 and held it in 4 quarters.
E.E. Geduld's Precigen position peaked at $734K in Q2 2015.
173 funds tracked by Wall St. Rank held Precigen as of Q3 2015.

Based on E.E. Geduld's 13F filing for Q3 2015, filed 6 Nov 2015.